This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Related letter  • Similar articles in this journal  Topic Collections  • Patient-Physician Relationship, Other  • Pediatrics  • Adolescent Psychiatry  • Cognitive Therapy  • Depression  • Psychopharmacology  • Suicide  • Patient Safety/ Medical Error  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

David Antonuccio, PhD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

When considering efficacy, the Treatment for Adolescents With Depression Study (TADS),¹ in my view the best comparative study ever done in children with depression, ranks the acute outcome of the treatments from best to worst this way: combination treatment, followed by fluoxetine hydrochloride therapy alone, followed by cognitive behavior therapy (CBT) alone, followed by placebo. Analysis of longer-term efficacy² suggests that CBT caught up with fluoxetine therapy at the 18-week follow-up and CBT caught up with the combination treatment at the 36-week follow-up (81% response for CBT, 81% response for fluoxetine therapy, and 85% response for combination treatment). When considering safety, the acute treatment rankings from best to worst were entirely different¹: CBT alone was best, followed by placebo, followed by combination treatment, followed by fluoxetine therapy alone. These safety rankings were maintained (suicidal events were 6.3% in CBT, 8.4% in combination treatment, and 14.7% in . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

The Treatment for Adolescents With Depression Study (TADS): Long-term Effectiveness and Safety Outcomes
The TADS Team
Arch Gen Psychiatry. 2007;64(10):1132-1143.
ABSTRACT | FULL TEXT  

Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression: Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial
Treatment for Adolescents With Depression Study Team
JAMA. 2004;292(7):807-820.
ABSTRACT | FULL TEXT  

RELATED LETTER

Tailoring Treatment to Parental Values: A Comment on TADS—Reply
John S. March and for the TADS Team
Arch Gen Psychiatry. 2008;65(6):723-724.
EXTRACT | FULL TEXT